These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 27980406

  • 21. Facile strategy by hyaluronic acid functional carbon dot-doxorubicin nanoparticles for CD44 targeted drug delivery and enhanced breast cancer therapy.
    Li J, Li M, Tian L, Qiu Y, Yu Q, Wang X, Guo R, He Q.
    Int J Pharm; 2020 Mar 30; 578():119122. PubMed ID: 32035259
    [Abstract] [Full Text] [Related]

  • 22. A surface-grafted ligand functionalization strategy for coordinate binding of doxorubicin at surface of PEGylated mesoporous silica nanoparticles: Toward pH-responsive drug delivery.
    Zhang Q, Zhao H, Li D, Liu L, Du S.
    Colloids Surf B Biointerfaces; 2017 Jan 01; 149():138-145. PubMed ID: 27750088
    [Abstract] [Full Text] [Related]

  • 23. Targeted anticancer prodrug with mesoporous silica nanoparticles as vehicles.
    Fan J, Fang G, Wang X, Zeng F, Xiang Y, Wu S.
    Nanotechnology; 2011 Nov 11; 22(45):455102. PubMed ID: 22019849
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Tumor microenvironment dual-responsive core-shell nanoparticles with hyaluronic acid-shield for efficient co-delivery of doxorubicin and plasmid DNA.
    Wang T, Yu X, Han L, Liu T, Liu Y, Zhang N.
    Int J Nanomedicine; 2017 Nov 11; 12():4773-4788. PubMed ID: 28740384
    [Abstract] [Full Text] [Related]

  • 26. Host-guest fabrication of dual-responsive hyaluronic acid/mesoporous silica nanoparticle based drug delivery system for targeted cancer therapy.
    Lu J, Luo B, Chen Z, Yuan Y, Kuang Y, Wan L, Yao L, Chen X, Jiang B, Liu J, Li C.
    Int J Biol Macromol; 2020 Mar 01; 146():363-373. PubMed ID: 31911174
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Reduction-sensitive CD44 receptor-targeted hyaluronic acid derivative micelles for doxorubicin delivery.
    Yang Y, Zhao Y, Lan J, Kang Y, Zhang T, Ding Y, Zhang X, Lu L.
    Int J Nanomedicine; 2018 Mar 01; 13():4361-4378. PubMed ID: 30100720
    [Abstract] [Full Text] [Related]

  • 29. Self-assembled pH-responsive hyaluronic acid-g-poly((L)-histidine) copolymer micelles for targeted intracellular delivery of doxorubicin.
    Qiu L, Li Z, Qiao M, Long M, Wang M, Zhang X, Tian C, Chen D.
    Acta Biomater; 2014 May 01; 10(5):2024-35. PubMed ID: 24365705
    [Abstract] [Full Text] [Related]

  • 30. Doxorubicin-tethered fluorescent silica nanoparticles for pH-responsive anticancer drug delivery.
    Zhang P, Kong J.
    Talanta; 2015 Mar 01; 134():501-507. PubMed ID: 25618700
    [Abstract] [Full Text] [Related]

  • 31. Thermo- and pH-responsive targeted lipid-coated mesoporous nano silica platform for dual delivery of paclitaxel and gemcitabine to overcome HER2-positive breast cancer.
    Nasri N, Saharkhiz S, Dini G, Yousefnia S.
    Int J Pharm; 2023 Dec 15; 648():123606. PubMed ID: 37972671
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Endosomal pH-Responsive Fe-Based Hyaluronate Nanoparticles for Doxorubicin Delivery.
    Bae Y, Kim Y, Lee ES.
    Molecules; 2021 Jun 10; 26(12):. PubMed ID: 34200716
    [Abstract] [Full Text] [Related]

  • 34. Tumor-targeted and multi-stimuli responsive drug delivery system for near-infrared light induced chemo-phototherapy and photoacoustic tomography.
    Feng Q, Zhang Y, Zhang W, Shan X, Yuan Y, Zhang H, Hou L, Zhang Z.
    Acta Biomater; 2016 Jul 01; 38():129-42. PubMed ID: 27090593
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. GE11 peptide modified and reduction-responsive hyaluronic acid-based nanoparticles induced higher efficacy of doxorubicin for breast carcinoma therapy.
    Hu D, Mezghrani O, Zhang L, Chen Y, Ke X, Ci T.
    Int J Nanomedicine; 2016 Jul 01; 11():5125-5147. PubMed ID: 27785019
    [Abstract] [Full Text] [Related]

  • 37. Graphene quantum dots-gated hollow mesoporous carbon nanoplatform for targeting drug delivery and synergistic chemo-photothermal therapy.
    Fang J, Liu Y, Chen Y, Ouyang D, Yang G, Yu T.
    Int J Nanomedicine; 2018 Jul 01; 13():5991-6007. PubMed ID: 30323587
    [Abstract] [Full Text] [Related]

  • 38. NIR and UV-responsive degradable hyaluronic acid nanogels for CD44-targeted and remotely triggered intracellular doxorubicin delivery.
    Hang C, Zou Y, Zhong Y, Zhong Z, Meng F.
    Colloids Surf B Biointerfaces; 2017 Oct 01; 158():547-555. PubMed ID: 28743090
    [Abstract] [Full Text] [Related]

  • 39. Intracellular pH-responsive and rituximab-conjugated mesoporous silica nanoparticles for targeted drug delivery to lymphoma B cells.
    Zhou S, Wu D, Yin X, Jin X, Zhang X, Zheng S, Wang C, Liu Y.
    J Exp Clin Cancer Res; 2017 Feb 06; 36(1):24. PubMed ID: 28166836
    [Abstract] [Full Text] [Related]

  • 40. pH and thermo dual-stimuli-responsive drug carrier based on mesoporous silica nanoparticles encapsulated in a copolymer-lipid bilayer.
    Wu X, Wang Z, Zhu D, Zong S, Yang L, Zhong Y, Cui Y.
    ACS Appl Mater Interfaces; 2013 Nov 13; 5(21):10895-903. PubMed ID: 24127854
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.